ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,431.60
      -0.04%
      US Tech 100
      19,168.00
      0.52%
      Dow Jones
      38,589.16
      -0.15%
      Brent Oil
      82.275
      0.00%
      Bitcoin
      66,482.04
      0.44%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU
      6. PHAXIAM Therapeutics SA (PHXM)

      7. PHAXIAM Therapeutics SA (PHXM) News

      PHXM

      PHAXIAM Therapeutics (PHXM)

      PHAXIAM Therapeutics SA
      		Date:
      Sort by:
       Showing the most relevant articles for your search:EU:PHXM
      DateTimeSourceHeadlineSymbolCompany
      06/12/20242:00AMGlobeNewswire Inc.Lancement d'une augmentation de capital avec maintien du DPS d’un montant d’environ 10 M€, susceptible d’être porté à environ 11,5 M€ en cas d’exercice intégral de la clause d'extensionEU:PHXMPHAXIAM Therapeutics SA
      06/07/202411:45AMGlobeNewswire Inc.PHAXIAM annonce les modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 28 juin 2024EU:PHXMPHAXIAM Therapeutics SA
      06/07/202411:45AMGlobeNewswire Inc.PHAXIAM announces the availability of the preparatory documents for the Combined General Meeting of 28 June 2024EU:PHXMPHAXIAM Therapeutics SA
      06/05/202412:00PMGlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 mai 2024EU:PHXMPHAXIAM Therapeutics SA
      06/05/202412:00PMGlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – May 31, 2024EU:PHXMPHAXIAM Therapeutics SA
      05/15/202411:45AMGlobeNewswire Inc.PHAXIAM Therapeutics fait le point sur ses activités et publie l’information financière du premier trimestre 2024EU:PHXMPHAXIAM Therapeutics SA
      05/15/202411:45AMGlobeNewswire Inc.PHAXIAM provides Business and Financial Update for the First Quarter of 2024EU:PHXMPHAXIAM Therapeutics SA
      05/03/202412:05PMGlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2024EU:PHXMPHAXIAM Therapeutics SA
      05/03/202412:05PMGlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2024EU:PHXMPHAXIAM Therapeutics SA
      04/15/20241:30AMGlobeNewswire Inc.PHAXIAM Therapeutics announces enrolment of the first patient in the phase 1 study for the treatment of endocarditis infections caused by Staphylococcus aureusEU:PHXMPHAXIAM Therapeutics SA
      04/15/20241:30AMGlobeNewswire Inc.PHAXIAM Therapeutics annonce le recrutement du premier patient dans l’étude de phase 1 dans l’endocardite infectieuse causée par le Staphylococcus aureusEU:PHXMPHAXIAM Therapeutics SA
      04/09/202412:00PMGlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 mars 2024EU:PHXMPHAXIAM Therapeutics SA
      04/09/202412:00PMGlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – March 29, 2024EU:PHXMPHAXIAM Therapeutics SA
      04/05/202412:00PMGlobeNewswire Inc.PHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)EU:PHXMPHAXIAM Therapeutics SA
      04/05/202412:00PMGlobeNewswire Inc.PHAXIAM Therapeutics annonce le dépôt de son Document d’Enregistrement Universel (URD) 2023EU:PHXMPHAXIAM Therapeutics SA
      03/11/20242:00AMGlobeNewswire Inc.PHAXIAM Therapeutics annonce la réalisation du retrait volontaire de ses « American Depository Shares » du Nasdaq Stock MarketEU:PHXMPHAXIAM Therapeutics SA
      03/11/20242:00AMGlobeNewswire Inc.PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock MarketEU:PHXMPHAXIAM Therapeutics SA
      03/11/20242:00AMGlobeNewswire Inc.PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock MarketEU:PHXMPHAXIAM Therapeutics SA
      03/05/202412:00PMGlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 février 2024EU:PHXMPHAXIAM Therapeutics SA
      03/05/202412:00PMGlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital - February 29, 2024EU:PHXMPHAXIAM Therapeutics SA
      02/20/20244:05PMGlobeNewswire Inc.PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital MarketEU:PHXMPHAXIAM Therapeutics SA
      02/20/20244:05PMGlobeNewswire Inc.PHAXIAM Therapeutics annonce son intention de procéder au retrait volontaire de ses « American Depositary Shares » du Nasdaq Capital MarketEU:PHXMPHAXIAM Therapeutics SA
      02/20/20244:05PMGlobeNewswire Inc.PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital MarketEU:PHXMPHAXIAM Therapeutics SA
      02/06/20244:05PMGlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital - January 31, 2024EU:PHXMPHAXIAM Therapeutics SA
      02/06/20244:05PMGlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2024EU:PHXMPHAXIAM Therapeutics SA
      01/18/20244:05PMGlobeNewswire Inc.PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024EU:PHXMPHAXIAM Therapeutics SA
      01/18/20244:05PMGlobeNewswire Inc.PHAXIAM Therapeutics annonce son niveau de trésorerie à fin 2023 et son calendrier financier 2024EU:PHXMPHAXIAM Therapeutics SA
      01/18/20244:05PMGlobeNewswire Inc.PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024EU:PHXMPHAXIAM Therapeutics SA
      01/03/20244:05PMGlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 décembre 2023EU:PHXMPHAXIAM Therapeutics SA
      01/03/20244:05PMGlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital - December 31, 2023EU:PHXMPHAXIAM Therapeutics SA
       Showing the most relevant articles for your search:EU:PHXM